UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058134
Receipt number R000066360
Scientific Title Evaluation of the effectiveness of alternating magnetic field therapy device (AT-04) for chemotherapy-induced peripheral neuropathy
Date of disclosure of the study information 2025/07/01
Last modified on 2025/06/08 13:32:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the effectiveness of the medical device AT-04 for peripheral neuropathy caused by anti-cancer drugs

Acronym

Examination of the effectiveness of the medical device AT-04 for peripheral neuropathy caused by anti-cancer drugs

Scientific Title

Evaluation of the effectiveness of alternating magnetic field therapy device (AT-04) for chemotherapy-induced peripheral neuropathy

Scientific Title:Acronym

Evaluation of the effectiveness of alternating magnetic field therapy device (AT-04) for chemotherapy-induced peripheral neuropathy

Region

Japan


Condition

Condition

Chemotherapy-Induced Peripheral Neuropathy

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective is to evaluate the efficacy and safety of alternating magnetic field therapy device AT-04 for the treatment of chemotherapy-induced peripheral neuropathy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in Pain and Numbness Numeric Rating Scale (NRS) at the Final Measurement

Key secondary outcomes

Change in Pain Numeric Rating Scale (NRS) at Each Observation Time Point
Change in EORTC QLQ-C30 and QLQ-CIPN20 Scores and Subscores at Each Observation Time Point
Patient Global Impression of Change (PGI-C) at Each Observation Time Point
Incidence of Adverse Events (CTCAE v.5.0)
Incidence of Device Malfunctions


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

AT-04 group: Treatment with the AT-04 alternating magnetic field therapy device. The device's leads were placed on four locations: both armpits and both groins, or the palms of both hands and the soles of both feet. The device was used for 30 minutes each time, at least twice a day (maximum of two hours), for 84 days.

Interventions/Control_2

Sham machine group: Treatment with the Sham machine.The device's leads were placed on four locations: both armpits and both groins, or the palms of both hands and the soles of both feet. The device was used for 30 minutes each time, at least twice a day (maximum of two hours), for 84 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with a 24-hour average pain NRS of 4/10 or more due to CIPN
Patients with peripheral sensory neuropathy of grade 1 or more in any limb based on CTCAE v5.0
Patients with an ECOG performance status of 0 to 2
Patients with a predicted prognosis of 12 weeks or more
Patients who have provided written informed consent

Key exclusion criteria

Patients who disagreed with the informed consent
Patients who are deemed inappropriate by the principal investigator or subinvestigator.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name SUNAO
Middle name
Last name SHOJI

Organization

Tokai University

Division name

Department of Urology

Zip code

259-1193

Address

Shimokasuya 143, Isehara, Kanagawa, Japan

TEL

0463-93-1121

Email

sunashoj@tokai.ac.jp


Public contact

Name of contact person

1st name SOICHIRO
Middle name
Last name YUZURIHA

Organization

Tokai University

Division name

Department of Urology

Zip code

259-1193

Address

Shimokasuya 143, Isehara, Kanagawa, Japan

TEL

0463-93-1121

Homepage URL


Email

ys6683@tokai.ac.jp


Sponsor or person

Institute

Tokai University

Institute

Department

Personal name



Funding Source

Organization

Tokai University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Tokai University

Address

Shimokasuya 143, Isehara, Kanagawa, Japan

Tel

0463-93-1121

Email

ys6683@tokai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 12 Month 02 Day

Date of IRB

2025 Year 02 Month 18 Day

Anticipated trial start date

2025 Year 05 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 10 Day

Last modified on

2025 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066360